3qlf: Difference between revisions

Revision as of 05:51, 9 February 2011 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,331,613 edits m Protected "3qlf" [edit=sysop:move=sysop] ← Older edit		Revision as of 09:38, 23 February 2011 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,331,613 edits No edit summary Newer edit →
Line 5:		Line 5:
	Authors: Boubeva, R., Pernot, L., Perozzo, R., Scapozza, L.		Authors: Boubeva, R., Pernot, L., Perozzo, R., Scapozza, L.

	Description: ~~CRYSTAL STRUCTURE OF THE~~ L317I ~~MUTANT OF THE~~ C-~~SRC TYROSINE KINASE DOMAIN COMPLEXED WITH PYRAZOLOPYRIMIDINE~~ 5		Description: Crystal structure of the L317I mutant of the C-src tyrosine kinase domain complexed with pyrazolopyrimidine 5

Navigation menu